Gupta, A., Love, S., Schuh, A., Shanyinde, M., Larkin, J., Plummer, R., . . . Middleton, M. (2014). DOC-MEK: A double-blind randomized phase II trial of docetaxel with or without selumetinib in wild-type BRAF advanced melanoma. Oxford University Press.
Cita Chicago Style (17a ed.)Gupta, A., et al. DOC-MEK: A Double-blind Randomized Phase II Trial of Docetaxel with or Without Selumetinib in Wild-type BRAF Advanced Melanoma. Oxford University Press, 2014.
Cita MLA (9a ed.)Gupta, A., et al. DOC-MEK: A Double-blind Randomized Phase II Trial of Docetaxel with or Without Selumetinib in Wild-type BRAF Advanced Melanoma. Oxford University Press, 2014.
Precaución: Estas citas no son 100% exactas.